KOPRAN
|
The Current P/B Ratio of KOPRAN is 1.22.
| Share Price | ₹130.9 | Dec 12,2025 |
| Market Cap | ₹632.2 Cr | |
| Book Value | ₹516.7 Cr | Mar2025 - Consolidated Results |
| Price/Book | 1.22x | Calculated as MarketCap/Book Value |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PB (Price/Book ) ratio of KOPRAN
P/B =
Market Capitalization
/ Book Value
or, using per-share numbers:
P/B = Stock Price /
Book Value Per Share
Current Market Cap [ ₹632.2 Cr] as on Dec 12,2025
(/) Book Value [ ₹516.7 Cr] based on Mar2025 - Consolidated Results
(=) P/B Ratio [ 1.22x ]
Thus, for KOPRAN , the investors are currently willing to pay '1.22 times book value' to own 1 share of the company.
PB Multiples are one of the most widely used valuation multiple in industry.
Since P/B ratio uses Book Value in the calculation, P/B multiples are not always reliable for valuing companies with negative book value.
In such cases, you may consider using Price to Earnings ratio or Price to Sales ratio of KOPRAN !
The chart below summarizes the trend in P/B Ratio of KOPRAN over the last five years.
Historical PB (Price/Book ) ratio chart of KOPRAN
PB Ratio Performance Analysis for KOPRAN
- KOPRAN 's p/b ratio for fiscal years ending Mar2025 to Mar2021 averaged 2.09x.
- KOPRAN 's operated at median p/b ratio of 1.85x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, KOPRAN 's p/b ratio peaked in Mar2022 at 3.19x.
- KOPRAN 's p/b ratio hit its five-year low in Mar2023 of 1.21x.
How does KOPRAN 's P/B Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Book Value | PB Ratio | Market Cap |
|---|---|---|---|
| KOPRAN | 516.73 | 1.22 | 632.2 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 72,218.00 | 5.96 | 430,513.0 |
| DIVIS LABORATORIES LTD | 14,969.00 | 11.40 | 170,614.0 |
| CIPLA LTD | 31,079.30 | 3.94 | 122,555.0 |
| TORRENT PHARMACEUTICALS LTD | 7,590.69 | 16.90 | 128,245.0 |
| DR REDDYS LABORATORIES LTD | 33,404.90 | 3.20 | 106,803.0 |
| MANKIND PHARMA LTD | 14,288.70 | 6.30 | 89,972.9 |
| ZYDUS LIFESCIENCES LTD | 23,953.10 | 3.90 | 93,484.2 |
| LUPIN LTD | 17,119.50 | 5.64 | 96,571.8 |
| AUROBINDO PHARMA LTD | 32,653.30 | 2.12 | 69,330.3 |
| ABBOTT INDIA LTD | 4,204.27 | 14.13 | 59,412.1 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PB Analysis vs KOPRAN 's P/B Ratio
| Top 10 Industry Peers | PB Ratio |
|---|---|
| Min industry PB | 1.22x |
| Max industry PB | 16.90x |
| Median industry PB | 5.64x |
| Average industry PB | 6.79x |
You may also like the below Video Courses